Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

SELL
$24.74 - $35.13 $160,810 - $228,345
-6,500 Reduced 42.76%
8,700 $234,000
Q4 2023

Feb 14, 2024

BUY
$21.62 - $37.21 $2,162 - $3,721
100 Added 0.66%
15,200 $544,000
Q3 2023

Nov 14, 2023

SELL
$27.34 - $55.37 $155,838 - $315,609
-5,700 Reduced 27.4%
15,100 $426,000
Q2 2023

Aug 14, 2023

SELL
$26.1 - $49.92 $274,050 - $524,160
-10,500 Reduced 33.55%
20,800 $1.04 Million
Q1 2023

May 15, 2023

BUY
$18.09 - $27.61 $390,744 - $596,376
21,600 Added 222.68%
31,300 $824,000
Q4 2022

Feb 14, 2023

SELL
$16.24 - $26.38 $95,815 - $155,642
-5,900 Reduced 37.82%
9,700 $181,000
Q3 2022

Nov 14, 2022

BUY
$23.95 - $34.71 $371,225 - $538,005
15,500 Added 15500.0%
15,600 $390,000
Q2 2022

Aug 08, 2022

SELL
$21.39 - $35.9 $554,001 - $929,810
-25,900 Reduced 99.62%
100 $3,000
Q1 2022

May 16, 2022

SELL
$24.84 - $36.12 $1.97 Million - $2.86 Million
-79,300 Reduced 75.31%
26,000 $887,000
Q4 2021

Feb 14, 2022

BUY
$33.38 - $59.25 $774,416 - $1.37 Million
23,200 Added 28.26%
105,300 $3.67 Million
Q3 2021

Nov 15, 2021

BUY
$53.75 - $76.55 $3.47 Million - $4.94 Million
64,500 Added 366.48%
82,100 $4.49 Million
Q2 2021

Aug 16, 2021

BUY
$59.02 - $78.8 $796,770 - $1.06 Million
13,500 Added 329.27%
17,600 $1.33 Million
Q1 2021

May 17, 2021

SELL
$64.61 - $113.09 $71,071 - $124,399
-1,100 Reduced 21.15%
4,100 $313,000
Q4 2020

Feb 16, 2021

SELL
$48.06 - $84.4 $302,778 - $531,720
-6,300 Reduced 54.78%
5,200 $412,000
Q3 2020

Nov 16, 2020

BUY
$46.87 - $93.33 $196,854 - $391,986
4,200 Added 57.53%
11,500 $546,000
Q2 2020

Aug 14, 2020

BUY
$36.12 - $91.57 $263,676 - $668,461
7,300 New
7,300 $668,000

Others Institutions Holding SDGR

About Schrodinger, Inc.


  • Ticker SDGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 62,028,400
  • Market Cap $1.22B
  • Description
  • Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...
More about SDGR
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.